Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Keystone Folding Box | Contract Pharma

What are you searching for?

Sign in

Search by

Keystone Folding Box

Company Headquarters

367 Verona Avenue , Newark, NJ, 07104, US

Driving Directions Phone: View Phone
View website

Request more information from Keystone Folding Box

Request more information from Keystone Folding Box

Categories from Keystone Folding Box

Manufacturing Equipment and Supplies
Manufacturing, Custom
Packaging, Anti-Counterfeiting
Packaging, Blister
Packaging, Clinical Trial Materials
Packaging, Compliance
Packaging, Development
Packaging, Injectables
Packaging, OTC
Packaging, Parenterals
Packaging, Samples
Packaging, Unit Dosage

Related Content

Promotions & Moves

Codis Promotes Steven Facer to Chief Commercial Officer

Facer offers 30+ years of leadership experience across pharmaceuticals, medical devices, and packaging.

By: Charlie Sternberg

Breaking News

Novo Nordisk to Acquire Three Obesity Drug Programs from Kallyope

Deal adds non-incretin obesity assets, including IND-ready peptide candidate K-554, as Novo seeks to broaden its metabolic pipeline.

By: Charlie Sternberg

Collaborations & Alliances

ProBio, Kun Tuo Partner to Accelerate Advancement of Innovative Therapies in China

The two companies will provide integrated support across CMC, non-clinical studies, and clinical operations.

By: Patrick Lavery

Breaking News

Kincell Bio, Cellipont Merge to Form Kincellis Advanced Therapies

New advanced therapies CDMO combines immune-cell, stem-cell and mRNA-enabled capabilities across three U.S. sites.

By: Charlie Sternberg

Breaking News

Charles River Launches Rapid Cell Banking Programs

New programs combine rapid microbiology testing and NGS characterization to shorten biologics development timelines.

By: Charlie Sternberg

Breaking News

Thermo Fisher Launches SuperScript V Reverse Transcriptase

Next-gen engineered enzyme designed to make the critical step of converting RNA to cDNA faster.

By: Charlie Sternberg

Marco Gil, co-CEO, Hovione; Janice Mironov, Mayor, East Windsor, NJ; Debbie Hart, President, BioNJ; Antonio Almeida, co-CEO, Hovione; David Basile, VP of TechOps - Americas, Hovione

Breaking News

Hovione Doubles US Spray-Drying Capacity With Opening of New NJ Facility

This closes a $100 million investment cycle, and creates approximately 80 new jobs.

By: Patrick Lavery

Collaborations & Alliances

Shilpa Biologicals, SPIMACO Bio Ink MENA Biosimilars Deal

Agreement covers PD-1 inhibitor biosimilars across Saudi Arabia and the wider MENA region.

By: Charlie Sternberg

Online Exclusives

CDMO Capacity: Stainless by Volume, Single-Use by Number

Large stainless-steel projects are rising, but pipeline demand is increasingly moving toward smaller, more flexible manufacturing models.

By: Dan Stanton

Promotions & Moves

Chiesi Group Appoints David Khougazian as CEO

Khougazian joins Chiesi following an international career spanning more than 25 years across the global healthcare and life sciences sectors.

By: Charlie Sternberg

Sponsored Videos

Fifty Years In, and Ropack Is Just Getting Started

To mark this important milestone, Ropack created a commemorative video that looks back on the past five decades.

Released By Ropack Pharma Solutions

Breaking News

Evonik Breaks Ground on New Biotechnology Expansion Project in Slovakia

The project is slated for completion in 2028 and will create approximately 50 new jobs.

By: Patrick Lavery

Promotions & Moves

Takeda R&D President Andy Plump to Retire in 2027

Takeda credits Plump with rebuilding its pipeline and advancing late-stage assets.

By: Charlie Sternberg

Collaborations & Alliances

Exegenesis Bio, Modalis Partner on DMD Gene Therapy

The collaboration pairs Exegenesis Bio’s EMC181 muscle-tropic AAV capsid with Modalis’ CRISPR-GNDM platform to advance MDL-201.

By: Charlie Sternberg

Breaking News

VVMF Sydney Facility Gets Therapeutic Goods Manufacturing License

The company hopes this will expand access to advanced therapeutics manufacturing not only in Australia, but also across Asia-Pacific.

By: Patrick Lavery